Top Markets
Coin of the day
Cytocom, Inc. Cytocom, Inc.

Cytocom, Inc.

CBLI
Classifica tra le azioni #27154
Cleveland BioLabs, Inc. functions as a biopharmaceutical firm, specializing in... Cleveland BioLabs, Inc. functions as a biopharmaceutical firm, specializing in the discovery and advancement of therapeutic drugs. Based in Buffalo, New York, the organization maintains a modest workforce of 15 full-time employees. Its primary objective involves pioneering methods to stimulate the body's immune defenses to tackle significant medical challenges. A core component of its work is a platform utilizing Toll-like immune receptor activators, which demonstrates utility in both alleviating radiation-induced damage and in the field of immuno-oncology. The most advanced therapeutic candidate in its pipeline is Entolimod, an immune-stimulating compound currently under development as a protective measure against radiation exposure and as an immunotherapy for various cancers and other indications. The company's portfolio also encompasses other promising products, including CBLB612, Mobilan, and CBL0137. CBLB612 is formulated from a natural stimulant that targets a specific component of the innate immune system: the heterodimeric receptor formed by toll-like receptors 2 (TLR2) and 6 (TLR6). Mobilan is a recombinant, non-replicating adenovirus engineered to induce the expression of TLR5 and its corresponding agonistic ligand. Lastly, CBL0137 is a small molecule characterized by a multi-faceted mechanism of action, suggesting its potential effectiveness across diverse forms of cancer.
Prezzo delle azioni
$3.17
Ultima sincronizzazione: 2021-08-31
Capitalizzazione di mercato
$34.83M
Variazione (1 giorno)
-7.31%
Variazione (1 anno)
0.00%
Paese
US
Scambia Cytocom, Inc. (CBLI)

Categoria

Storico del prezzo dell'azione per Cytocom, Inc. (CBLI)
Prezzo di chiusura più alto: $3.41 il 2021-08-01

Prezzo di chiusura più basso: $5.25 il 2006-07-01
Storico del prezzo dell'azione di Cytocom, Inc. dal 2006 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2021 11.35%
2020 339.14%
2019 -56.76%
2018 -50.61%
2017 106.92%
2016 -58.57%
2015 1,023.55%
2014 -70.42%
2013 -16.31%
2012 -52.26%
2011 -59.48%
2010 101.16%
2009 75.24%
2008 -75.44%
2007 67.93%
2006 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$760.05 6.79%
CH